[{"address1": "11400 West Olympic Boulevard", "address2": "Suite 200", "city": "Los Angeles", "state": "CA", "zip": "90064", "country": "United States", "phone": "310 651 8041", "website": "https://www.immixbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia. The company' lead product is NXC-201 for relapsed/refractory AL Amyloidos. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California.", "fullTimeEmployees": 18, "companyOfficers": [{"maxAge": 1, "name": "Dr. Ilya  Rachman M.B.A., M.D., MBA, Ph.D.", "age": 51, "title": "Co-Founder, CEO & Chairman", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 669000, "exercisedValue": 0, "unexercisedValue": 1846232}, {"maxAge": 1, "name": "Mr. Gabriel  Morris B.A.", "age": 37, "title": "CFO & Director", "yearBorn": 1987, "fiscalYear": 2023, "totalPay": 669000, "exercisedValue": 0, "unexercisedValue": 3188312}, {"maxAge": 1, "name": "Dr. Graham  Ross FFPM, M.D.", "age": 64, "title": "Chief Medical Officer & Head of Clinical Development", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 104423, "exercisedValue": 0, "unexercisedValue": 55346}, {"maxAge": 1, "name": "Mr. Sean  Senn J.D., M.B.A., M.Sc., MBA, MSc", "title": "Co-Founder", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Vladimir P. Torchilin D.Sc., MSE, Ph.D.", "age": 77, "title": "Scientific Co-Founder", "yearBorn": 1947, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nandan  Oza B.S.", "age": 62, "title": "Head of Chemistry, Manufacturing & Control", "yearBorn": 1962, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Marks MBBS, Ph.D.", "title": "Chief Medical Officer of Cell Therapy", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gerhard  Bauer", "title": "Head of Cell Therapy Manufacturing", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.75, "open": 1.7042, "dayLow": 1.7, "dayHigh": 1.8842, "regularMarketPreviousClose": 1.75, "regularMarketOpen": 1.7042, "regularMarketDayLow": 1.7, "regularMarketDayHigh": 1.8842, "payoutRatio": 0.0, "beta": 0.294, "forwardPE": -3.3999999, "volume": 68176, "regularMarketVolume": 68176, "averageVolume": 57749, "averageVolume10days": 34250, "averageDailyVolume10Day": 34250, "bid": 1.31, "ask": 2.24, "bidSize": 2, "askSize": 2, "marketCap": 51840328, "fiftyTwoWeekLow": 1.26, "fiftyTwoWeekHigh": 2.71, "fiftyDayAverage": 1.69316, "twoHundredDayAverage": 1.873735, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 35233156, "profitMargins": 0.0, "floatShares": 17986658, "sharesOutstanding": 27722100, "sharesShort": 346837, "sharesShortPriorMonth": 386334, "sharesShortPreviousMonthDate": 1740700800, "dateShortInterest": 1743379200, "sharesPercentSharesOut": 0.0125, "heldPercentInsiders": 0.39786997, "heldPercentInstitutions": 0.12037, "shortRatio": 6.58, "shortPercentOfFloat": 0.0392, "impliedSharesOutstanding": 27722100, "bookValue": 0.481, "priceToBook": 3.887734, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -21613376, "trailingEps": -0.76, "forwardEps": -0.55, "enterpriseToEbitda": -1.556, "52WeekChange": -0.11792451, "SandP52WeekChange": 0.07995045, "quoteType": "EQUITY", "currentPrice": 1.87, "targetHighPrice": 7.0, "targetLowPrice": 7.0, "targetMeanPrice": 7.0, "targetMedianPrice": 7.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 17681954, "totalCashPerShare": 0.638, "ebitda": -22641740, "totalDebt": 1074770, "quickRatio": 2.263, "currentRatio": 2.325, "debtToEquity": 8.111, "returnOnAssets": -0.66110003, "returnOnEquity": -1.47334, "freeCashflow": -7551199, "operatingCashflow": -14595102, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "IMMX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Immix Biopharma, Inc.", "longName": "Immix Biopharma, Inc.", "regularMarketChangePercent": 6.8571434, "regularMarketPrice": 1.87, "corporateActions": [], "postMarketTime": 1745612647, "regularMarketTime": 1745611202, "exchange": "NCM", "messageBoardId": "finmb_417356223", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1639665000000, "postMarketChangePercent": 1.60428, "postMarketPrice": 1.9, "postMarketChange": 0.03, "regularMarketChange": 0.120000005, "regularMarketDayRange": "1.7 - 1.8842", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 57749, "fiftyTwoWeekLowChange": 0.61, "fiftyTwoWeekLowChangePercent": 0.48412699, "fiftyTwoWeekRange": "1.26 - 2.71", "fiftyTwoWeekHighChange": -0.84000003, "fiftyTwoWeekHighChangePercent": -0.3099631, "fiftyTwoWeekChangePercent": -11.792451, "earningsTimestamp": 1742846400, "earningsTimestampStart": 1746648000, "earningsTimestampEnd": 1747080000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.76, "epsForward": -0.55, "epsCurrentYear": -0.68, "priceEpsCurrentYear": -2.75, "fiftyDayAverageChange": 0.17683995, "fiftyDayAverageChangePercent": 0.10444373, "twoHundredDayAverageChange": -0.0037349463, "twoHundredDayAverageChangePercent": -0.0019933162, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-12-16", "cryptoTradeable": false, "marketState": "CLOSED", "displayName": "Immix Biopharma", "trailingPegRatio": null, "__fetch_time": "2025-04-26"}]